Infrared Fluorescent Protein

Biliverdin serves as the light-absorbing pigment associated with the reporter’s fluorescent output. Infrared fluorescent proteins can use biliverdin already present in the biological system or receive supplemented pigment, allowing the chromophore to form without introducing a separate fluorescent dye. This feature supports genetically encoded labeling strategies for cells and tissues in living cancer models.

Near-infrared light generally encounters less biological autofluorescence than visible wavelengths and can penetrate tissue more effectively. These properties improve the distinction between labeled cancer cells and surrounding tissue, while allowing observations through living samples. Consequently, researchers can visualize tumor-associated processes with less background interference than would be expected from visible-light reporters.

Signal formation depends on the reporter’s ability to bind biliverdin, which may be endogenous or supplemented, and on the use of excitation light appropriate for the resulting chromophore. Tissue context also matters because absorption, penetration, and biological autofluorescence influence detection. Together, these variables affect how clearly labeled cells or tissues can be visualized.

When engineered cancer cells carry an IFP reporter, imaging can follow those cells across time as the disease develops. The resulting observations can relate cellular location or persistence to tumor growth, invasion, or metastasis. This longitudinal connection helps researchers examine how labeled cell populations participate in progression rather than relying only on a single endpoint.

A conceptual workflow begins by genetically encoding the reporter in the cancer cells or other cells of interest. The labeled cells are then observed in a living model using near-infrared excitation and fluorescence detection, with biliverdin available endogenously or through supplementation. Repeated imaging can track changes in tumor-associated behavior over the course of the study.

IFP imaging is suited to studies that require repeated visualization of labeled cells or tissues during tumor growth, invasion, metastasis, or treatment. It can also support assessment of therapeutic responses by revealing changes in the labeled cancer-cell population or tumor-associated signal over time. Reduced background and tissue penetration make these applications compatible with noninvasive observation in living models.